Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $823.3400 (-1.04%) ($822.1200 - $836.3800) on Fri. Sep. 15, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.69% (three month average) | RSI | 45 | Latest Price | $823.3400(-1.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(66%) IBB(60%) DIA(54%) XLF(54%) SDY(50%) | Factors Impacting REGN price | REGN will decline at least -0.845% in a week (0% probabilities). VXX(-45%) VIXM(-42%) EDOC(-29%) TBT(-20%) USO(-18%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.845% (StdDev 1.69%) | Hourly BBV | -2.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $829.74 | 5 Day Moving Average | $829.49(-0.74%) | 10 Day Moving Average | $827.41(-0.49%) | 20 Day Moving Average | $829.74(-0.77%) | To recent high | -2.5% | To recent low | 18.9% | Market Cap | $87.298b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |